SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001136261-19-000116
Filing Date
2019-03-26
Accepted
2019-03-26 16:55:40
Documents
3
Period of Report
2019-03-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K body8k.htm 8-K 21971
2 NON-EMPLOYEE DIRECTOR COMPENSATION POLICY exh10-1.htm EX-10.1 9343
3 EMPLOYMENT AGREEMENT BY AND BETWEEN SEELOS THERAPEUTICS, INC. AND RAJ MEHRA, PH. exh10-2.htm EX-10.2 55468
  Complete submission text file 0001136261-19-000116.txt   88155
Mailing Address 300 PARK AVENUE NEW YORK NY 10017
Business Address 300 PARK AVENUE NEW YORK NY 10017 (646) 998-6475
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22245 | Film No.: 19705835
SIC: 2834 Pharmaceutical Preparations